RE:RE:RE:RE:Little sedi action. We know there is a desperate need for our product. We don't know if PFE is off the board or not. With a 10bln target value, they could easily fund a deal with cash/stock and still pay 30bln for Seagen. Will they? I don't know. However, we are working with the likes of Merck Kga, Roche, Bristol and others - any of whom could easily fund our purchase. Don't forget patent cliffs total 10's of billions over the next decade. We will fill part of that void. I've been invested for 16 years and have taken many gut punches ( like many of you) but I believe we are closer than ever to getting a deal done.
If Matt's comment on having 2 P3 trials going by year end is accurate, we need a deal in place by the end of March at the latest. Even the biggest Pharmas need 6 months to prep and plan for a pivotal trial. The best case is 2 accelated approvals followed by a buy out announcement. Either way, we are close IMO. Fox - keep the faith.